Libin Li
Observed names: Li-Bin Li, Li-bin LI, Li-bin Li, LiBin Li, Li‐Bin Li
Observed institutions: Butler University, F. Hoffmann-La Roche AG, Merck & Co., Inc., Rahway, NJ, USA (United States), Fujian Medical University, Biogen (United States), United States Department of Health and Human Services, National Institutes of Health, United States Food and Drug Administration, National Institute on Drug Abuse, Center for Drug Evaluation and Research, Children's Hospital of Philadelphia, Netherlands Organisation for Applied Scientific Research, Sun Yat-sen University, Merck KGaA, Darmstadt (Germany), Duquesne University, Eli Lilly (United States), Pfizer (United States), Genentech, University of Washington, Chinese PLA General Hospital, Bristol-Myers Squibb (United States), GlaxoSmithKline (United States), BD Biosciences (United States), First Affiliated Hospital of Fujian Medical University, Second Affiliated Hospital of Fujian Medical University, Absorption Systems (United States), Sanofi (Germany), AstraZeneca (Sweden), Sun Yat-sen University Cancer Center, Solvo Biotechnology (Hungary), Eisai (United States), Optivia Biotechnology (United States), Second Affiliated Hospital of Zhejiang University, Boehringer Ingelheim (United States), Simcyp (United Kingdom), State Key Laboratory of Oncology in South China, Rutgers New Jersey Medical School, Takeda Oncology (United States), University of Medicine and Dentistry of New Jersey, Illinois State University, Tianjin Medical University, Chongqing Jiaotong University, Drexel University, Zhejiang University, University of Pennsylvania, Hebei Normal University
ORCID: 0000-0002-5185-7720
Observed ORCID: 0000-0002-5185-7720
OpenAlex ID: A5101825508
